L
Lauren P Westhaver
Researcher at Dalhousie University
Publications - 7
Citations - 22
Lauren P Westhaver is an academic researcher from Dalhousie University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 1 publications receiving 6 citations.
Papers
More filters
Journal ArticleDOI
Raloxifene prevents stress granule dissolution, impairs translational control and promotes cell death during hypoxia in glioblastoma cells.
Kathleen M. Attwood,Aaron Robichaud,Lauren P Westhaver,Elizabeth L. Castle,David M. Brandman,Aruna D. Balgi,Michel Roberge,Patricia Colp,Sidney E Croul,Inhwa Kim,Craig McCormick,Jennifer A. Corcoran,Adrienne Weeks +12 more
TL;DR: Findings indicate that modulating the stress response can be used to exploit the hypoxic niche of GBM tumors, causing cell death by disrupting pro-survival stress responses and control of protein synthesis.
Journal ArticleDOI
Mitochondrial damage-associated molecular patterns trigger arginase-dependent lymphocyte immunoregulation.
Lauren P Westhaver,Sarah Nersesian,A. Nelson,Leah K. MacLean,Emily B Carter,Derek Rowter,Jun Wang,Boris Gala-Lopez,Andrew W. Stadnyk,Brent Johnston,Jeanette E. Boudreau +10 more
TL;DR: In this article , the authors describe the lymphocyte response to mitoDAMPs and demonstrate that natural killer (NK) cells and T cells adopt regulatory phenotypes and functions in response.
Journal ArticleDOI
PAXgene Fixation for Pancreatic Cancer: Implications for Molecular and Surgical Pathology
Ryan DeCoste,Yutaka Amemiya,Sarah Nersesian,Lauren P Westhaver,Stacey N. Lee,Michael A. Carter,Heidi Sapp,Ashley Stueck,Thomas Arnason,Jeanette E. Boudreau,Arun Seth,Weei-Yuarn Huang +11 more
TL;DR: The results support the use of PAXgene fixative for the processing of specimens from pancreatic cancers with the potential benefits of improved yields for more amplifiable DNA in low-yield biopsy specimens and its ideal use for amplicon-based NGS assays.
Journal ArticleDOI
Predicting Early Graft Dysfunction and Mortality After Liver Transplant Using the De Ritis Ratio.
TL;DR: In this article , the De Ritis ratio (DRR), a widely known parameter of liver dysfunction, was incorporated into current or future scoring models to predict early allograft dysfunction and mortality after liver transplantation.
Journal ArticleDOI
Changing liver utilization and discard rates in clinical transplantation in the ex-vivo machine preservation era
TL;DR: A review of the history of ex-vivo liver machine preservation can be found in this paper , where the authors provide a brief overview of the major drivers of organ discard (age, ischemia time, steatosis etc.) and how this technology may ultimately revert such a trend.